Arch Venture Fund VIII Overage, 10% Owner: Neumora Therapeutics NMRA Buy · Filed 25/10/29

Trade details

Type: Insider buy
Amount: $4,999,977
Shares · price: 1,915,700 sh · $2.61 a share
Held after: 6,046,907 sh
Stock: Neumora Therapeutics NMRA
Person: Arch Venture Fund VIII Overage10% Owner
Trade date: 25/10/27
Filed: 25/10/29
Days to filing: 2 days

First buy in 2 years

Since the last buy: 2.1 years
Last buy: 23/09/19
Insiders buying this week: 18 insiders
Holding change: +46.4%

Neumora Therapeutics trades, last 26 weeks

What else happened in Neumora Therapeutics around then

Filed or reported within 30 days of the trade day · 25/09/27~25/11/26

Arch Venture Fund VIII Overage's recent trades

Arch Venture Fund VIII Overage10% Owner
BuyNeumora Therapeutics
Buy
Neumora Therapeutics
NMRA
$25.5M
1,500,000 sh
$25.5M
Filed 23/09/20
Traded 23/09/19